Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million Dec 15, 2025 04:00PM
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million Sep 15, 2025 04:50PM
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million Sep 15, 2025 03:55PM
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025 Sep 10, 2025 04:30PM
Champions Oncology (CSBR) Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House Apr 28, 2025 09:47AM


Apr 28, 2025 09:45AM Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Mar 6, 2025 04:00PM Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Feb 18, 2025 09:00AM Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
Jan 8, 2025 08:03AM Champions Oncology (CSBR) Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Jan 8, 2025 08:00AM Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Jul 11, 2024 04:05PM Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
Jun 4, 2024 09:00AM Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Mar 7, 2024 09:00AM Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Nov 2, 2023 11:36AM Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung
Nov 2, 2023 08:30AM Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
Oct 17, 2023 08:33AM Champions Oncology (CSBR) Appoints Brady Davis as President
Oct 17, 2023 08:30AM Champions Oncology Announces the Addition of Brady Davis as President
Aug 22, 2023 08:30AM Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
Aug 1, 2023 08:46AM Champions Oncology (CSBR) Enters Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Aug 1, 2023 08:45AM Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Apr 17, 2023 08:30AM Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
May 31, 2022 08:30AM Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 3, 2022 08:30AM Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
Feb 15, 2022 08:30AM Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
Jan 20, 2022 08:33AM Champions Oncology (CSBR) Enters Partnership with Fannin Innovation to Develop Therapeutic Raptamer Drug Conjugates
Jan 20, 2022 08:30AM Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
Jan 4, 2022 08:30AM Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
Jul 26, 2021 08:30AM Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
Jan 19, 2021 09:00AM Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics
Nov 16, 2020 04:40PM Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program
Nov 11, 2020 09:00AM Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform
Jan 29, 2020 09:00AM The Children's Cancer Therapy Development Institute is collaborating with Champions Oncology and The Jackson Laboratory to provide RACE Act/PREA pediatric cancer study plan services
Aug 31, 2015 10:00AM Champions Oncology, Inc. (Nasdaq: CSBR) to Ring The Nasdaq Stock Market Closing Bell
Aug 31, 2015 10:00AM Champions Oncology, Inc. (Nasdaq: CSBR) to Ring The Nasdaq Stock Market Closing Bell